Gregory Laforge

Gregory Laforge is currently working as an Associate Director, FP&A at CRISPR Therapeutics. Gregory previously held positions at Translate Bio as a Manager, Finance, Thermo Fisher Scientific as a Lexington Site Finance Business Partner, Brammer Bio as a Senior Financial Analyst, FP&A, PAREXEL as a Project Financial Analyst, and Putnam Investments as an Investor Service Representative. Gregory graduated from the University of Massachusetts Lowell with a Bachelor's degree in Business - Finance.